Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 2018, Article ID 6296071, 5 pages
https://doi.org/10.1155/2018/6296071
Research Article

Risk Evaluation of Endoscopic Retrograde Cholangiopancreatography-Related Contrast Media Allergic-Like Reaction: A Single Centre Experience

Gastroenterology, Department of Medicine, CHUS, Sherbrooke, QC, Canada

Correspondence should be addressed to Félix Trottier-Tellier; moc.liamg@efittort

Received 17 October 2017; Revised 10 January 2018; Accepted 23 January 2018; Published 15 February 2018

Academic Editor: Salvatore Oliva

Copyright © 2018 Félix Trottier-Tellier et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. K. Bilbao, C. T. Dotter, T. G. Lee, and R. M. Katon, “Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases,” Gastroenterology, vol. 70, no. 3, pp. 314–320, 1976. View at Google Scholar · View at Scopus
  2. D. Mishkin, S. Carpenter, J. Croffie et al., “ASGE technology status evaluation report: radiographic contrast media used in ERCP,” Gastrointestinal Endoscopy, vol. 62, no. 4, pp. 480–484, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Mann, J. Rendl, R. Busley et al., “Systemic iodine absorption during endoscopic application of radiographic contrast agents for endoscopic retrograde cholangiopancreaticography,” European Journal of Endocrinology, vol. 130, no. 5, pp. 498–501, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. K. D. Hopper, S. J. Wegert, and S. E. Hallgren, “Renal excretion of endoscopic retrograde cholangiopancreatography injected contrast a common phenomenon,” Investigative Radiology, vol. 24, no. 5, pp. 394–396, 1989. View at Publisher · View at Google Scholar · View at Scopus
  5. S. D. Ladas, T. Rokkas, J. Kaskarelis, J. Hatzioannou, and S. Raptis, “Absorption of iodized contrast media during ERCP,” Gastrointestinal Endoscopy, vol. 32, no. 5, p. 376, 1986. View at Publisher · View at Google Scholar · View at Scopus
  6. M. H. Roszler and W. L. Campbell, “Post-ERCP pancreatitis: Association with urographic visualization during ERCP,” Radiology, vol. 157, no. 3, pp. 595–598, 1985. View at Publisher · View at Google Scholar · View at Scopus
  7. R. A. Sable, W. S. Rosenthal, J. Siegel, R. Ho, and R. H. Jankowski, “Absorption of contrast medium during ERCP,” Digestive Diseases and Sciences, vol. 28, no. 9, pp. 801–806, 1983. View at Publisher · View at Google Scholar · View at Scopus
  8. J.-J. Pan and P. V. Draganov, “Adverse reactions to iodinated contrast media administered at the time of endoscopic retrograde cholangiopancreatography (ERCP),” Inflammation & Allergy - Drug Targets, vol. 8, no. 1, pp. 17–20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. K. Morcos and H. S. Thomsen, “Adverse reactions to iodinated contrast media,” European Radiology, vol. 11, no. 7, pp. 1267–1275, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Bettmann, T. Heeren, A. Greenfield, and C. Goudey, “Adverse events with radiographic contrast agents: results of the SCVIR contrast agent registry,” Radiology, vol. 203, no. 3, pp. 611–620, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. K. J. Mortelé, M.-R. Oliva, S. Ondategui, P. R. Ros, and S. G. Silverman, “Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital,” American Journal of Roentgenology, vol. 184, no. 1, pp. 31–34, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. F. Kopp, K. J. Mortele, Y. D. Cho, P. Palkowitsch, M. A. Bettmann, and C. D. Claussen, “Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients,” Acta Radiologica, vol. 49, no. 8, pp. 902–911, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. P. V. Draganov, A. L. Suarez, and P. B. Cotton, “Variability in management of ERCP-related contrast media reaction,” Gastrointestinal Endoscopy, vol. 82, no. 5, pp. 973-974, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. Committee on drugs and contrast media of the american college of radiology, “ACR Manual on Contrast Media Version 10.1,” 2015.
  15. P. V. Draganov and C. E. Forsmark, “Prospective evaluation of adverse reactions to iodine-containing contrast media after ERCP,” Gastrointestinal Endoscopy, vol. 68, no. 6, pp. 1098–1101, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. V. F. Moreira, E. Merono, J. L. Larraona et al., “ERCP and allergic reactions to iodized contrast media,” Gastrointestinal Endoscopy, vol. 31, no. 4, p. 293, 1985. View at Publisher · View at Google Scholar · View at Scopus
  17. M. F. Catalano and E. Schwartz, “Use of iodine-based contrast during ERCP in patients with iodine allergy,” The American Journal of Gastroenterology, pp. 88–1528, 1993. View at Google Scholar
  18. F. Trottier-Tellier, L. Harvey, H. Bernard, and J. Baillargeon, Risk evaluation of endoscopic retrograde cholangiopancreatography related contrast media allergic reaction among patients known for adverse reaction to iodine containing product, 2018, https://www.cag-acg.org/publications/cag-scientific-publications/2017-cddw-abstracts/abstract-library/abstracts/poster-presentation/a325.html. View at Publisher · View at Google Scholar